Nzeera Ketter Selected Research

vanutide cridificar

1/2017	Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
1/2016	Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nzeera Ketter Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2014
5	Edema (Dropsy) 01/2018 - 01/2014
4	Ventilator-Associated Pneumonia 01/2010 - 04/2008
3	Dementia (Dementias) 01/2021 - 01/2016
2	Healthcare-Associated Pneumonia 01/2009 - 07/2008
2	Infections 02/2007 - 11/2006
2	HIV Infections (HIV Infection) 02/2007 - 11/2006
1	Seizures (Absence Seizure) 01/2009
1	Urinary Tract Infections (Urinary Tract Infection) 01/2009
1	Intraabdominal Infections 01/2009
1	Hepatitis C 04/2008
1	Cross Infection (Nosocomial Infection) 04/2008

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
6	bapineuzumabIBA 01/2018 - 01/2014
4	Doripenem FDA Link 01/2010 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
3	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2014
3	VaccinesIBA 01/2017 - 11/2006
2	ApolipoproteinsIBA 01/2018 - 01/2014
2	Monoclonal AntibodiesIBA 01/2018 - 01/2014
2	vanutide cridificarIBA 01/2017 - 01/2016
2	saponin QA-21V1 (QS21)IBA 01/2017 - 01/2016
2	Imipenem FDA Link 01/2009 - 04/2008
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2009 - 07/2008
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2009 - 07/2008
2	AntibodiesIBA 04/2008 - 11/2006
2	AIDS VaccinesIBA 02/2007 - 11/2006
1	Biological ProductsIBA 01/2021
1	HemosiderinIBA 01/2017
1	Amyloid beta-PeptidesIBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	GABA Receptors (GABA Receptor)IBA 01/2009
1	Meropenem (Merrem)FDA LinkGeneric 01/2009
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2008
1	Immunoglobulin G (IgG)IBA 02/2007
1	EnzymesIBA 02/2007

Therapy/Procedure

3	Therapeutics 01/2016 - 01/2010
1	Length of Stay 04/2008